Transcranial direct current stimulation as a strategy to manage COVID-19 pain and fatigue
Rev. Assoc. Med. Bras. (1992)
;
67(1): 26-28, Jan. 2021. graf
Artículo
en Inglés
| LILACS
| ID: biblio-1287782
ABSTRACT
SUMMARY The novel coronavirus disease (COVID-19) has infected millions of people worldwide and generated many sequels in the survivors, such as muscular pain and fatigue. These symptoms have been treated through pharmacological approaches; however, infected people keep presenting physical limitations. Besides, the COVID-19 damage to the central nervous system has also been related to the presence of some physical impairment, so strategies that focus on diverse brain areas should be encouraged. Transcranial Direct Current Stimulation (tDCS) is a non-pharmacological tool that could be associated with pharmacological treatments to improve the central nervous system function and decrease the exacerbation of the immune system response. tDCS targeting pain and fatigue-related areas could provide an increase in neuroplasticity and enhancements in physical functions. Moreover, it can be used in infirmaries and clinical centers to treat COVID-19 patients.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Estimulación Transcraneal de Corriente Directa
/
COVID-19
Tipo de estudio:
Estudio de etiología
Límite:
Humanos
Idioma:
Inglés
Revista:
Rev. Assoc. Med. Bras. (1992)
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
UniversidadeFederal da Paraíba/BR
Similares
MEDLINE
...
LILACS
LIS